You are here

Protocol for Narrowing the Gap in Adjuvant Therapy (GAP Study)

Vanessa Sheppard, PhD, Georgetown University, Washington, DC
Study abstract

At present, it is estimated that adjuvant therapy would be considered standard of care for up to 80% of women with invasive, non-metastatic disease, but many Black women eligible for adjuvant therapy are not receiving it or are receiving sub-optimal regimens. However, at present there are few data about Black women’s breast cancer experiences or factors that influence treatment adherence.

Study review

This study at Georgetown University, in Washington, DC, was designed to better understand the differences in breast cancer treatment experiences between African-American women and white women. The researchers wanted to enroll at least 400 African-American women and 400 white women. The Call to Action for this study was sent to Army of Women members on April 3, 2009. When the researchers closed enrollment on August 2, 2011, the Army of Women had provided them with 239 women who were interested in enrolling in the study.

Research Webinar:
The GAP Study

Resulting Publications: